A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.

A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Abstract Text:

Nonalcoholic fatty liver disease (NAFLD), hypertriglyceridemia, and elevated free fatty acids are present in the majority of patients with metabolic syndrome and type 2 diabetes mellitus and are strongly associated with hepatic insulin resistance. In the current study, we tested the hypothesis that an increased rate of fatty acid oxidation in liver would prevent the potentially harmful effects of fatty acid elevation, including hepatic triglyceride (TG) accumulation and elevated TG secretion. Primary rat hepatocytes were transduced with adenovirus encoding carnitine palmitoyltransferase 1a (Adv-CPT-1a) or control adenoviruses encoding either beta-galactosidase (Adv-beta-gal) or carnitine palmitoyltransferase 2 (Adv-CPT-2). Overexpression of CPT-1a increased the rate of beta-oxidation and ketogenesis by approximately 70%, whereas esterification of exogenous fatty acids and de novo lipogenesis were unchanged. Importantly, CPT-1a overexpression was accompanied by a 35% reduction in TG accumulation and a 60% decrease in TG secretion by hepatocytes. There were no changes in secretion of apolipoprotein B (apoB), suggesting the synthesis of smaller, less atherogenic VLDL particles. To evaluate the effect of increasing hepatic CPT-1a activity in vivo, we injected lean or obese male rats with Adv-CPT-1a, Adv-beta-gal, or Adv-CPT-2. Hepatic CPT-1a activity was increased by approximately 46%, and the rate of fatty acid oxidation was increased by approximately 44% in lean and approximately 36% in obese CPT-1a-overexpressing animals compared with Adv-CPT-2- or Adv-beta-gal-treated rats. Similar to observations in vitro, liver TG content was reduced by approximately 37% (lean) and approximately 69% (obese) by this in vivo intervention. We conclude that a moderate stimulation of fatty acid oxidation achieved by an increase in CPT-1a activity is sufficient to substantially reduce hepatic TG accumulation both in vitro and in vivo. Therefore, interventions that increase CPT-1a activity could have potential benefits in the treatment of NAFLD.

A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: American journal of physiology. Endocrinology and

VOLUME: 294

Page Numbers: E969-77

Journal Abbreviation: Am. J. Physiol. Endocrinol. Me

ISSN: 0193-1849

DAY: 18

MONTH: 03

YEAR: 2008

A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100901226

A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.

AFFILIATION: Univ. of Pittsburgh Medical Center, Division of Endocrinology, E1112 Biomedical Science Tower, Pittsburgh, PA 15261. stefanovicracicm@upmc.edu).

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Am J Physiol Endocrinol Metab

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels Related Publications

• A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
• A new hearing test applicable to the crying newborn infant.
• A palladium-catalyzed glycosylation reaction: the de novo synthesis of natural and unnatural glycosides.
• A stereoselective synthesis of digitoxin and digitoxigen mono- and bisdigitoxoside from digitoxigenin via a palladium-catalyzed glycosylation.
• Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells.
• Anterior tibial artery pseudoaneurysm in a patient with hemophilia: a complication of ankle arthroscopy.
• De Novo Asymmetric Synthesis of 8a-epi-Swainsonine.
• De novo approach to 2-deoxy-beta-glycosides: asymmetric syntheses of digoxose and digitoxin.
• De novo asymmetric syntheses of SL0101 and its analogues via a palladium-catalyzed glycosylation.
• De novo asymmetric syntheses of muricatacin and its analogues via dihydroxylation of dienoates.
• De novo asymmetric synthesis of milbemycin beta3 via an iterative asymmetric hydration approach.
• De novo asymmetric synthesis of the anthrax tetrasaccharide by a palladium-catalyzed glycosylation reaction.
• De novo formal synthesis of (-)-apicularen A via an iterative asymmetric hydration sequence.
• De novo formal synthesis of (-)-virginiamycin M2 via the asymmetric hydration of dienoates.
• De novo synthesis of 2-substituted syn-1,3-diols via an iterative asymmetric hydration strategy.
• De novo synthesis of oligosaccharides using a palladium-catalyzed glycosylation reaction.
• Determining the neural substrates of goal-directed learning in the human brain.
• Glucuronidase and lipids in wallerian degeneration.
• HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration.
• Imaging neuroendocrine tumours with radionuclide techniques.
• Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle.
• Lights, camembert, action! The role of human orbitofrontal cortex in encoding stimuli, rewards, and choices.
• Positron emission tomography and the orthopaedic surgeon.
• Preparation and stability of a radioiodinated pentamidine isethionate analog.
• Reinforcement learning signals in the human striatum distinguish learners from nonlearners during reward-based decision making.
• Synthesis of aza-analogues of the glycosylated tyrosine portion of mannopeptimycin-E.
• The de novo synthesis of oligosaccharides: application to the medicinal chemistry SAR-study of digitoxin.
• The influence of manure composition on emissions of odour and ammonia from finishing pigs fed different concentrations of dietary crude protein.
• [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
• [Sinterloy technic. Ceramic framework of metallic powder]